(Q36465559)

14 August 2017

1 reference

title

Inflammatory cytokines: interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases (English)

1 reference

14 August 2017

0 references

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(05)80018-4

24 October 2022

1

Dinarello CA

1 reference

14 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1665333

24 October 2022

publication date

1 December 1991

1 reference

full work available at URL

14 August 2017

https://api.elsevier.com/content/article/PII:S0952791505800184?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(05)80018-4

https://api.elsevier.com/content/article/PII:S0952791505800184?httpAccept=text/plain

24 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(05)80018-4

Current Opinion in Immunology

24 October 2022

published in

1 reference

14 August 2017

3

1 reference

14 August 2017

941-948

1 reference

14 August 2017

6

1 reference

Relationship between interleukin 1 (IL1), tumor necrosis factor (TNF) and a neutrophil attracting peptide (NAP-1).

14 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

Mechanisms of matrix degradation in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

Cytokines as immune effector molecules in autoimmune endocrine diseases with special reference to insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

Identification and mapping to chromosome 1 of a susceptibility locus for periinsulitis in non-obese diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

Type 1 diabetes in mice is linked to the interleukin-1 receptor and Lsh/lty/Bcg genes on chromosome 1

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

Preliminary report: effects of interleukin-1 on platelet counts

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

Protection against pulmonary oxygen toxicity by interleukin-1 and tumor necrosis factor: role of antioxidant enzymes and effect of cyclooxygenase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

In vitro enhanced thromboxane B2 release by polymorphonuclear leukocytes and macrophages after treatment with human recombinant interleukin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

Interleukin-1 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

Interleukin 1 inhibitory activity secreted by a human myelomonocytic cell line (M20)

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

Purification and characterization of a 26-kDa competitive inhibitor of interleukin 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

A natural interleukin 1 (IL-1) inhibitor counteracts the inhibitory effect of IL-1 on insulin production in cultured rat pancreatic islets

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s)

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

Interleukin-1 receptor antagonist reduces mortality from endotoxin shock

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

A specific receptor antagonist for interleukin 1 prevents Escherichia coli ‐induced shock in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

Interleukin 1 suppresses inflammation in rabbit colitis. Mediation by endogenous prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

Interleukin 1-dependent paracrine granulopoiesis in chronic granulocytic leukemia of the juvenile type

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

Production of interleukin-1-receptor antagonist during experimental endotoxaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

Monoclonal antibodies reacting with the interleukin 1 receptor define a multi-molecular complex

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

Soluble cytokine receptors are present in normal human urine

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

Regulation of alloreactivity in vivo by a soluble form of the interleukin-1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2805%2980018-4

7 January 2021

Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity

series ordinal

6

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(05)80018-4

Interleukin 1 receptor blockade attenuates the host inflammatory response

24 October 2022

series ordinal

60

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(05)80018-4

24 October 2022

Identifiers

1 reference

14 August 2017

1 reference